Navigation Links
Reportlinker Adds Bladder Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Volume 1 2011
Date:4/12/2011

ssia, Patient Volume (absolute), 2001–2010 211

Table 116: Bladder Cancer Therapeutics Market, Russia, Treatment Usage Patterns, 2001–2010 212

Table 117: Bladder Cancer Therapeutics Market, Russia, Sales Value ($m), 2011-2020 217

Table 118: Bladder Cancer Therapeutics Market, Russia, Annual Cost of Therapy ($), 2011-2020 218

Table 119: Bladder Cancer Therapeutics Market, Russia, Patient Volume (absolute), 2011-2020 219

Table 120: Bladder Cancer Therapeutics Market, Russia, Treatment Usage Patterns, 2011-2020 220

Table 121: Bladder Cancer Therapeutics Market, Russia, Drug Sales ($m), 2001-2010 223

Table 122: Bladder Cancer Therapeutics Market, Russia, Drug Sales ($m), 2011-2020 224

Table 123: Major Marketed Products Comparison in the Bladder Cancer Therapeutics Market, 2010 235

Table 124: Bladder Cancer Therapeutics – Most Promising Drugs Under Clinical Development, 2010 238

Table 125: Clinical Trial Results for Javlor, April 2009 239

Table 126: Bladder Cancer Therapeutics – Phase III Clinical Pipeline 244

Table 127: Bladder Cancer Therapeutics – Phase II Clinical Pipeline 245

Table 128: Bladder Cancer Therapeutics – Phase I Clinical Pipeline 246

Table 129: Bladder Cancer Therapeutics – Pre-clinical Pipeline 247

Table 130: Bladder Cancer Therapeutics – Discontinued/Suspended Drugs 247

Table 131: Bladder Cancer Therapeutics Market, Global, Clinical Trials by Status, January 2011 248

Table 132: Bladder Cancer Therapeutics Market, Global, Clinical Trials by Country, January 2011 250

Table 133: Bladder Cancer Therapeutics Market, Global, Clinical Trials by Phase, January 2011 251

Table 134: Bladder Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type, January 2011 252

Table 135: Bladder Cancer Therapeutics Market, Global, Clinical Trials, Leading Sponsors, January 2011 253
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23

Related medicine technology :

1. Reportlinker Adds Continuous Glucose Monitoring (CGM) Systems - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016
2. Reportlinker Adds World In Vitro Diagnostics Market
3. Reportlinker Adds Global Market for Medical Devices, 2nd Edition
4. Reportlinker Adds European Markets for Patient Monitoring Devices and Equipment 2011(15 Countries)
5. Reportlinker Adds Asia Pacific Markets for Dental Bone Graft Substitutes and Other Biomaterials 2011
6. Reportlinker Adds European Markets for Interventional Cardiology Devices 2011 (15 Countries)
7. Reportlinker Adds Global: Pharmaceuticals Industry Guide
8. Reportlinker Adds Asian Vaccine Markets
9. Reportlinker Adds Microscopy Market in Latin America
10. Reportlinker Adds Leading Anti-Cancer Drugs: World Market Prospects 2011-2021
11. Reportlinker Adds Transdermal Drug Delivery - Technologies, Markets, and Companies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... 2014  Strategic Health Services, Inc. (SHS), a leading ... a strategic agreement with QualCare, Inc., a leading provider of ... regional marketplace.  This agreement will further QualCare,s population ... solutions QualCare brings to its clients in ... QualCare plans cover more than 800,000 member ...
(Date:12/17/2014)... , Dec. 17, 2014  ImmunoCellular Therapeutics, ... US Patent and Trademark Office (USPTO) has issued ... a dendritic cell-based immunotherapeutic vaccine targeting six tumor ... claims of US Patent No. 8,871,211, which issued ... cancer by administering a dendritic cell composition comprising ...
(Date:12/15/2014)... Registreer nu via  http://bit.ly/ag8Sypm14de ... Februar sind alle akkreditierten pharmazeutischen Patientenversorgungsakten-Firmen (PMR) ... PROGRAMM ™ 2015 in Amsterdam ... Tagung soll dazu beitragen, der Aegate PMR ... profitablen Unternehmensdienstleistungen, die für Apotheken und die ...
Breaking Medicine Technology:Strategic Health Services to collaborate with QualCare on Population Health and Wellness Technology for QualCare Members 2Strategic Health Services to collaborate with QualCare on Population Health and Wellness Technology for QualCare Members 3ImmunoCellular Therapeutics Announces Issuance of Key Patent For ICT-107 Cancer Vaccine 2Symposium über Aegates Ecosystem-Partner-Programm für sichere Medikamente vom 19. - 20. Februar 2015 in Amsterdam 2
... Market Trends, Growth Strategies, and SWOT... -- DALLAS, Texas, August 31, 2010 ... ... ... // Results are keyed by longUrl, so we need to grab the first one. for (var r ...
... Dermatology Market (Drugs, Therapeutic Segments and Disorders) (2010 to 2015)... -- DALLAS, August 31, 2010 ... ... ... ,; var first_result; // Results are keyed by longUrl, so we need to grab the first one. ...
Cached Medicine Technology:The Top 10 Cardiovascular Device Companies: Market Trends, Growth Strategies, and SWOT Analyses Now Available at ReportsandReports 2The Top 10 Cardiovascular Device Companies: Market Trends, Growth Strategies, and SWOT Analyses Now Available at ReportsandReports 3The Top 10 Cardiovascular Device Companies: Market Trends, Growth Strategies, and SWOT Analyses Now Available at ReportsandReports 4The Top 10 Cardiovascular Device Companies: Market Trends, Growth Strategies, and SWOT Analyses Now Available at ReportsandReports 5The Top 10 Cardiovascular Device Companies: Market Trends, Growth Strategies, and SWOT Analyses Now Available at ReportsandReports 6The Top 10 Cardiovascular Device Companies: Market Trends, Growth Strategies, and SWOT Analyses Now Available at ReportsandReports 7The Top 10 Cardiovascular Device Companies: Market Trends, Growth Strategies, and SWOT Analyses Now Available at ReportsandReports 8The Top 10 Cardiovascular Device Companies: Market Trends, Growth Strategies, and SWOT Analyses Now Available at ReportsandReports 9New Report World Dermatology Market (Drugs, Therapeutic Segments and Disorders) (2010 to 2015) Published By MarketsandMarkets 2New Report World Dermatology Market (Drugs, Therapeutic Segments and Disorders) (2010 to 2015) Published By MarketsandMarkets 3New Report World Dermatology Market (Drugs, Therapeutic Segments and Disorders) (2010 to 2015) Published By MarketsandMarkets 4New Report World Dermatology Market (Drugs, Therapeutic Segments and Disorders) (2010 to 2015) Published By MarketsandMarkets 5New Report World Dermatology Market (Drugs, Therapeutic Segments and Disorders) (2010 to 2015) Published By MarketsandMarkets 6New Report World Dermatology Market (Drugs, Therapeutic Segments and Disorders) (2010 to 2015) Published By MarketsandMarkets 7New Report World Dermatology Market (Drugs, Therapeutic Segments and Disorders) (2010 to 2015) Published By MarketsandMarkets 8New Report World Dermatology Market (Drugs, Therapeutic Segments and Disorders) (2010 to 2015) Published By MarketsandMarkets 9
(Date:12/17/2014)... A group of 127 scientists sent an ... reaction to a recent statement by the center that was ... derogated the efficacy of all brain exercises. , Signatories to ... of the center’s statement critical of brain exercise companies that ... overstated its case, in a document it had entitled “A ...
(Date:12/17/2014)... 2014 (HealthDay News) -- As gas prices rose in ... new study suggests. In times of gas increases, ... riders are inexperienced, the researchers explained. They examined ... has the highest number of motorcycle registrations in the ... deaths. The analysis revealed a strong association between ...
(Date:12/17/2014)... HealthDay Reporter TUESDAY, Dec. ... fast approaching, a new study reveals that states that routinely ... drunk drivers on their roads. The finding suggests that ... able to deter inebriated revelers from getting behind the wheel ... being passed regarding drinking and driving," said study lead author ...
(Date:12/15/2014)... CITY, NV (PRWEB) December 15, 2014 ... powerhouse company, JM Ocean Avenue. JM Ocean Avenue ... of the Veretekk online automated marketing system. JM ... the June 2014 merger of Ocean Avenue and JM ... more than $2 Billion per year company. , “After ...
(Date:12/15/2014)... December 15, 2014 Health Dialog, ... announced today that it has received Patient Oriented ... (NCQA) for its Disease Management (DM) Programs for ... (COPD), coronary heart disease and diabetes. This marks ... for Health Dialog’s Disease Management (DM) Programs, reaffirming ...
Breaking Medicine News(10 mins):Health News:Scientists to Stanford: Research Shows Brain Exercises Can Work 2Health News:Scientists to Stanford: Research Shows Brain Exercises Can Work 3Health News:Scientists to Stanford: Research Shows Brain Exercises Can Work 4Health News:When Gas Prices Go Up, So Do Motorcycle Accidents, Study Finds 2Health News:Enforcement of Drunk Driving Laws Makes Roads Safer, Study Finds 2Health News:Enforcement of Drunk Driving Laws Makes Roads Safer, Study Finds 3Health News:JM Ocean Avenue secures the strategic advantages of Veretekk 2Health News:JM Ocean Avenue secures the strategic advantages of Veretekk 3Health News:JM Ocean Avenue secures the strategic advantages of Veretekk 4Health News:Health Dialog Receives NCQA Accreditation for Disease Management Programs 2
... to Host Conference Call at 10 a.m. EST, January ... Medical,Innovations (AMEX: IMA ) and Matria Healthcare, Inc. ... into a definitive agreement pursuant to,which Inverness will acquire ... per share, payable $6.50 in cash plus $32.50 in,convertible ...
... Surgeons, Jolie, Kidman, Anderson, Loren, Bundchen, Pitt, and ... hear it every day, "Oh, I wish I,could look ... I,d do anything.",With increasing availability of aesthetic plastic surgery, ... some of these wishes are coming true. But do ...
... protease ... ABBOTT PARK, Ill., Jan. 28 Abbott (NYSE: ... Medicinal Products for Human Use,(CHMP), the scientific committee of ... recommending approval of a new,lower-strength tablet formulation of the ...
... 28 Shazaaam! LLC, an integrated,marketing communications ... Public Relations and Marketing Communications Agency of,Record ... will provide social marketing, proactive and reactive,blogging, ... enhance,ETC,s branding and visibility among its target ...
... January 28 Gerresheimer,AG has quickly completed the ... manufacturer of glass and plastic products for the,pharmaceutics ... continues its global expansion, on 21 December 2007. ... and Argentina (Buenos,Aires) specialises in pharma containers based ...
... Defense has commissioned a nine-month study from Rice University ... determine whether a new drug based on carbon nanotubes ... injury following radiation exposure. The new study was commissioned ... 5,000 times more effective at reducing the effects of ...
Cached Medicine News:Health News:Inverness Medical Innovations Enters Into a Definitive Agreement to Acquire Matria Healthcare, Inc. 2Health News:Inverness Medical Innovations Enters Into a Definitive Agreement to Acquire Matria Healthcare, Inc. 3Health News:Inverness Medical Innovations Enters Into a Definitive Agreement to Acquire Matria Healthcare, Inc. 4Health News:Inverness Medical Innovations Enters Into a Definitive Agreement to Acquire Matria Healthcare, Inc. 5Health News:Inverness Medical Innovations Enters Into a Definitive Agreement to Acquire Matria Healthcare, Inc. 6Health News:Celebrity Influences on Plastic Surgery 2Health News:Celebrity Influences on Plastic Surgery 3Health News:Celebrity Influences on Plastic Surgery 4Health News:Abbott's Kaletra(R) and Aluvia(R) (lopinavir/ritonavir) New Lower-Strength Tablet for Pediatric Use Receives Positive Opinion from EMEA 2Health News:Abbott's Kaletra(R) and Aluvia(R) (lopinavir/ritonavir) New Lower-Strength Tablet for Pediatric Use Receives Positive Opinion from EMEA 3Health News:Abbott's Kaletra(R) and Aluvia(R) (lopinavir/ritonavir) New Lower-Strength Tablet for Pediatric Use Receives Positive Opinion from EMEA 4Health News:Abbott's Kaletra(R) and Aluvia(R) (lopinavir/ritonavir) New Lower-Strength Tablet for Pediatric Use Receives Positive Opinion from EMEA 5Health News:Abbott's Kaletra(R) and Aluvia(R) (lopinavir/ritonavir) New Lower-Strength Tablet for Pediatric Use Receives Positive Opinion from EMEA 6Health News:Abbott's Kaletra(R) and Aluvia(R) (lopinavir/ritonavir) New Lower-Strength Tablet for Pediatric Use Receives Positive Opinion from EMEA 7Health News:Abbott's Kaletra(R) and Aluvia(R) (lopinavir/ritonavir) New Lower-Strength Tablet for Pediatric Use Receives Positive Opinion from EMEA 8Health News:Shazaaam! Named PR Agency of Record for Enuresis Treatment Center 2Health News:Feds fund study of drug that may prevent radiation injury 2
... a medical device designed to handle the ... and archiving demands of the EEG laboratory. ... that helps organize workflow and the collection, ... database and powerful search capability keeps track ...
... The P3000 heralds a new concept in pupillometry, ... infrared optical system developed for the P2000. ... in which we have paid particular attention to ... Our new system is extremely flexible, allowing you ...
...
... Peg electrodes typically are ... to enable epidural recording of ... contacts and are furnished in ... skull thicknesses. A 4.6 mm ...
Medicine Products: